Fresenius Medical Care AG (FMS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Company Overview - Fresenius Medical Care is currently stronger and more resilient, with a clear strategy aimed at driving profitable growth and long-term value creation [3] - The company has embarked on its strategy, with 2026 identified as a significant transition year, focusing on setting a new standard of care in the United States through a large-scale conversion of clinics with a new therapy [3] Industry Insights - The fundamentals of the kidney care industry remain intact, largely unaffected by broader macroeconomic cycles [5] - Structural drivers such as an aging population, chronic conditions like hypertension and diabetes, and increased recognition of chronic kidney disease as a public health crisis continue to support global demand for kidney care services [5]